Sodium –glucose cotransporter 2 inhibitors and skeletal muscle
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 2, 2024 Category: Cardiology Authors: Andrew J. Stewart Coats Tags: Invited Editorial Source Type: research
Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful or futile?
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 2, 2024 Category: Cardiology Authors: Herminio Morillas,
Julio N úñez,
Pedro Moliner Tags: Invited Editorial Source Type: research
Comorbidities and cardiac resynchronization therapy: Do we talk the talk or should we walk the walk?
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 2, 2024 Category: Cardiology Authors: Domenico D'Amario,
Renzo Laborante,
Pasquale Santangeli Tags: Invited Editorial Source Type: research
Interatrial shunt therapy in advanced heart failure: Outcomes from the open ‐label cohort of the RELIEVE‐HF trial
ConclusionInteratrial shunting with the Ventura device was safe and resulted in favourable clinical effects in patients with HF, regardless of LVEF. Improvements of left and right ventricular structure and function were consistent with reverse myocardial remodelling. These results would support the potential of this shunt device as a treatment for HF. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 2, 2024 Category: Cardiology Authors: Josep Rod és‐Cabau,
JoAnn Lindenfeld,
William T. Abraham,
Michael R. Zile,
Saibal Kar,
Antoni Bayés‐Genís,
Neal Eigler,
Richard Holcomb,
Julio Núñez,
Elizabeth Lee,
Michal Laufer Perl,
Gil Moravsky,
Michael Pfeiffer,
John Boehmer,
J Tags: Research Article Source Type: research
Cost ‐effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS‐HF system) in chronic heart failure in the Netherlands
ConclusionsThe current cost-effectiveness study suggests that remote haemodynamic monitoring with PA-guided therapy on top of standard care is likely to be cost-effective for patients with symptomatic moderate-to-severe HF in the Netherlands. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 1, 2024 Category: Cardiology Authors: Hamraz Mokri,
Pascal R.D. Clephas,
Rudolf A. de Boer,
Pieter van Baal,
Jasper J. Brugts,
Maureen P.M.H. Rutten ‐van Mölken Tags: Research Article Source Type: research
Body mass index and cardiorenal outcomes in the EMPEROR ‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial
ConclusionsEmpagliflozin treatment resulted in broadly consistent cardiac effects across the range of BMI in patients with HFpEF. SGLT2i treatment yields benefit in patients with HFpEF regardless of baseline BMI. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 1, 2024 Category: Cardiology Authors: Naveed Sattar,
Javed Butler,
Matthew M.Y. Lee,
Josephine Harrington,
Abhinav Sharma,
Faiez Zannad,
Gerasimos Filippatos,
Subodh Verma,
James L. Januzzi,
Jo ão Pedro Ferreira,
Stuart J. Pocock,
Egon Pfarr,
Anne P. Ofstad,
Martina Brueckmann, Tags: Research Article Source Type: research
Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF
ConclusionAmong patients discharged after hospitalization for HF, there was no significant difference in clinical and patient-reported outcomes between torsemide and furosemide, irrespective of renal function. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 1, 2024 Category: Cardiology Authors: Pieter Martens,
Stephen J. Greene,
Robert J. Mentz,
Shuang Li,
Daniel Wojdyla,
Chris J. Kapelios,
Wilfried Mullens,
Michael E. Hall,
Fassil Ketema,
Dong ‐Yun Kim,
Eric L. Eisenstein,
Kevin Anstrom,
James C. Fang,
Bertram Pitt,
Eric J. Vela Tags: Research Article Source Type: research
Serial direct sodium removal in patients with heart failure and diuretic resistance
ConclusionsIn patients with HF and diuretic resistance, serial DSR therapy with loop diuretic withdrawal was feasible and associated with substantial and persistent improvement in diuretic resistance and several cardiorenal parameters. If replicated in randomized controlled studies, DSR may represent a novel therapy for diuretic resistance and CRS.Clinical Trial Registration: RED DESERT (NCT04116034), SAHARA (NCT04882358). (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 1, 2024 Category: Cardiology Authors: Veena S. Rao,
Juan B. Ivey ‐Miranda,
Zachary L. Cox,
Julieta Moreno‐Villagomez,
Daniela Ramos‐Mastache,
Daniel Neville,
Natasha Balkcom,
Jennifer L. Asher,
Lavanya Bellumkonda,
Tamar Bigvava,
Tamaz Shaburishvili,
Jozef Bartunek,
F. Perry Tags: Research Article Source Type: research
More than just a clinical syndrome: Biomarkers and echocardiography should be rapidly advised for anyone with suspected heart failure!
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 28, 2024 Category: Cardiology Authors: Erwan Donal,
Louis Gegout,
K. Charlotte Lee Tags: Invited Editorial Source Type: research
Temporary mechanical circulatory support for cardiogenic shock: Definitive intervention or ancillary bridging therapy? Letter regarding the article ‘What about current recommendations for extracorporeal life support in acute myocardial infarction‐associated cardiogenic shock: Stay or go? or time to revise?’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 26, 2024 Category: Cardiology Authors: Jonathan R. Dalzell,
Jane A. Cannon Tags: Letter to the Editor Source Type: research
Pre ‐diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank
ConclusionsSex hormones potentially influence HF pathogenesis and may offer pathways for interventions. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 26, 2024 Category: Cardiology Authors: Jungeun Lim,
Maryam Hashemian,
Batel Blechter,
V éronique L. Roger,
Jason Y.Y. Wong Tags: Research Article Source Type: research
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort
ConclusionIn individuals without heart failure, LAVi was associated with MMP-2, IGFBP-2 and NT-proBNP. Spironolactone reduced these biomarker concentrations as well as LAVi and PICP, irrespective of left atrial size. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 26, 2024 Category: Cardiology Authors: Masatake Kobayashi,
Jo ão Pedro Ferreira,
Duarte Kevin,
Emmanuel Bresso,
Olivier Huttin,
Erwan Bozec,
Hans‐Peter Brunner La Rocca,
Christian Delles,
Andrew L. Clark,
Frank Edelmann,
Arantxa González,
Stephane Heymans,
Pierpaolo Pellicori, Tags: Research Article Source Type: research
Global longitudinal strain as a predictor of risk in patients with heart failure with preserved ejection fraction: A deserved role?
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 26, 2024 Category: Cardiology Authors: Francois Deharo,
Julia Grapsa Tags: Invited Editorial Source Type: research
The pharmacist ally in heart failure: Useful when involved. Letter regarding the article ‘Effective medications can work only in patients who take them: Implications for post‐acute heart failure care’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 26, 2024 Category: Cardiology Authors: Lorenz Van der Linden,
Fatma Karapinar ‐Carkıt,
Paul Forsyth Tags: Letter to the Editor Source Type: research
Corrigendum to ‘Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 26, 2024 Category: Cardiology Tags: CORRIGENDUM Source Type: research
